Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott Becomes First Anchor Sponsor For American Diabetes Association Health Equity Now Initiative

Executive Summary

Abbott will commit $5m to support the ADA’s efforts to bring diabetes technologies and education to underserved diabetes populations.

You may also be interested in...



Abbott Partners With ADA On Nutrition Program

Abbott providing $2.65m to American Diabetes Association to study how continuous glucose monitoring systems can help people with diabetes improve their diet and exercise habits.

Minute Insight: Abbott Partners With ADA On Nutrition Program

Abbott is providing $2.65m to the American Diabetes Association to study how continuous glucose monitoring systems can help people with diabetes improve their diet and exercise habits.

Abbott Wants To Expand Clinical Trial Access By Diversifying Investigator Community

The company’s plan to reduce barriers to clinical trial participation for underrepresented groups includes the creation of nearly 300 new scholarships at medical schools of historically black colleges and universities and minority nursing associations.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT143098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel